Illumina sees bright biotech future with 23andMe

09/13/2007 | Forbes

Illumina has partnered with 23andMe, a startup backed by Google and Genentech, in an aim to further strengthen its place in the biotech industry. Under the joint venture, Illumina would sample the genome of 23andMe customers and provide the results of DNA variations to 23andMe, which would make the information available to customers through a secure Web site.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care